| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 24,1 k € | +30.2% | 18,5 k € | +171.9% | -25,7 k € | -227.9% | 20,1 k € | -0.1% | 20,1 k € | -0.1% | 20,1 k € | -0.0% | 20,1 k € | +0.9% | 20,0 k € | +0.1% | 19,9 k € | -5.7% | 21,1 k € | +500.8% | 3,5 k € | |
| EBITDA | 22,8 k € | +29.2% | 17,7 k € | +165.8% | -26,9 k € | -241.4% | 19,0 k € | -0.2% | 19,1 k € | -0.3% | 19,1 k € | -3.2% | 19,7 k € | +1.0% | 19,5 k € | +0.6% | 19,4 k € | -5.7% | 20,6 k € | +4139.8% | -510,0 € | |
| Operating profit | 20,5 k € | +33.7% | 15,3 k € | +150.3% | -30,4 k € | -296.8% | 15,5 k € | -0.3% | 15,5 k € | -0.4% | 15,6 k € | +32.8% | 11,7 k € | +1.8% | 11,5 k € | +1.0% | 11,4 k € | -9.4% | 12,6 k € | +247.3% | -8,5 k € | |
| Profit/loss | 16,6 k € | +11.1% | 14,9 k € | +147.6% | -31,3 k € | -414.8% | 9,9 k € | -3.0% | 10,3 k € | +6.7% | 9,6 k € | +65.8% | 5,8 k € | +36.4% | 4,3 k € | -47.8% | 8,1 k € | -9.2% | 9,0 k € | +177.6% | -11,6 k € | |
| Equity | 51,9 k € | +46.9% | 35,3 k € | +73.1% | 20,4 k € | -60.5% | 51,7 k € | +23.8% | 41,8 k € | +32.6% | 31,5 k € | +43.9% | 21,9 k € | +36.0% | 16,1 k € | +35.9% | 11,9 k € | +219.7% | 3,7 k € | +170.4% | -5,3 k € | |
| Total assets | 126,4 k € | +8.0% | 117,0 k € | +0.1% | 116,9 k € | +3.9% | 112,5 k € | -6.9% | 120,9 k € | +2.2% | 118,3 k € | -5.4% | 125,1 k € | -3.4% | 129,5 k € | -3.4% | 134,0 k € | -2.9% | 138,0 k € | -1.8% | 140,6 k € | |
| Cash | 34,1 k € | +75.9% | 19,4 k € | -7.2% | 20,9 k € | +23.3% | 16,9 k € | -22.2% | 21,8 k € | +39.6% | 15,6 k € | -17.3% | 18,9 k € | +24.1% | 15,2 k € | +35.8% | 11,2 k € | +45.9% | 7,7 k € | +336.1% | 1,8 k € | |
| Debts | 71,9 k € | -10.1% | 79,9 k € | -15.6% | 94,7 k € | +60.5% | 59,0 k € | -23.7% | 77,3 k € | -10.9% | 86,8 k € | -15.9% | 103,2 k € | -9.0% | 113,4 k € | -7.2% | 122,1 k € | -9.1% | 134,3 k € | -7.9% | 145,8 k € | |
Source: Belgian Official Gazette
Private limited company · Seraing · incorporated on 04/04/2014
Private limited company profitable and well capitalised. Cash position rising (+75.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
ORTHOTEC INVEST is a Private limited company incorporated in 2014. Its registered office is in Seraing.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.